Portal for

    You are here

    Warning message

    Attention! This event has already passed.

    Revolutionizing Next-Generation Sequencing (3rd edition) 25-26 MARCH 2019, ANTWERP, BELGIUM

    Monday, 25 March, 2019 - 08:30 to Tuesday, 26 March, 2019 - 18:00
    BluePoint Antwerpen
    Filip Williotstraat 9 2600 Berchem

    Revolutionizing Next-Generation Sequencing (3rd edition)

    25-26 mARCH 2019, ANTWERP, BELGIUM 

    After two successful editions (Jan 2015, Leuven and March 2017, Antwerp), VIB is proud to present the third edition of this Tools & Technologies conference.

    VIB believes that the revolutionary discoveries enabled by NGS are not yet at its zenith and that the technology can go much further. During this 3rd edition VIB will bring together over 30 top scientists and technology developers from both industry and academia. They will discuss emerging tools and approaches in several sessions such as:

    • Long reads, Genome Structure and Mapping
    • Epigenomics
    • Metagenomics
    • Spatial transcriptomics
    • Population Scale and Clinical Sequencing
    • Single Cell Sequencing
    • Emerging technologies

    In addition to a great scientific and technology program, the conference will provide ample opportunities to network during the breaks, poster sessions and the conference dinner.

    Also young scientists are encouraged to showcase their own work to the international research community by oral or poster presentation!

    Information for poster submissions:

    The format for your poster should be: A0 (841 x 1189 mm / 33.1 x 46.8 in), portrait orientation


    • Early Bird: 11/02/2019
    • Late Registration: 11/03/2019
    • Abstract deadline: 21/01/2019

    Website link: https://vibconferences.be/event/revolutionizing-next-generation-sequencing-3rd-edition 


    BluePoint Antwerpen
    Filip Williotstraat 9
    2600 Berchem

    Speakers including:

    • Todd Dickinson - CEO, Dovetail Genomics, US
    • Kristopher Nazor – BioLegend, US
    • Wolf Reik - Babraham Institute, UK
    • Bas Van Steensel - NKI, NL
    • Gabriella Ficz - Barts Cancer Institute, UK
    • Long Cai - California Institute of Technology, US
    • Andreas Tolias - Baylor College of Medicine, US
    • Malte Kühnemund - Cartana, SE
    • Stevan Jovanovich - S2 Genomics, US
    • Dennis Eastburn - CSO, Mission Bio, US
    • Winston Timp - Johns Hopkins University, Baltimore, Maryland, US
    • Alexander Hoischen - Radboud University Medical Center, NL
    • Vladimir MakaroV - Swift Bioscience, US
    • Chris Bowler - IBENS, FR